Sort   by:  
 Page size 
MetabolomicsInositol polyphosphates regulate resilient mechanisms in the green alga Chlamydomonas reinhardtii to adapt to extreme nutrient conditions

In the actual context of climate changing environments, photosynthetic organisms need to adapt to more extreme conditions. Microalgae can be excellent organisms to understand molecular mechanisms that activate survival mechanisms under stress. Chlamydomonas reinhardtii signaling mutants are extre...

2024-12-05 | MTBLS10779 | MetaboLights
ProteomicsADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes
Libraries of single-stranded oligodeoxynucleotides (ssODNs) can be enriched for sequences that specifically bind molecules on naïve complex biological samples like cells or tissues. Depending on the enrichment strategy, the ssODNs can identify molecules specifically associated with a defined biologi...
ORGANISM(S): Homo sapiens (Human) 
2020-01-13 | PXD011496 | Pride
Prostate cancer cells Escrt complex Aptamers Adapt Exosomes 
UnknownCardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).
Not available
S-EPMC1851724 | biostudies-literature
UnknownSubcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).
Not available
S-EPMC11579873 | biostudies-literature
GenomicsPlasmodium knowlesi can adapt to infect Duffy-negative Erythrocytes - nanopore reads
Plasmodium knowlesi can adapt to infect Duffy-negative Erythrocytes - nanopore reads
PRJEB90622 | ENA
UnknownFacilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study.
Not available
S-EPMC6889057 | biostudies-literature
GenomicsPlasmodium knowlesi can adapt to infect Duffy-negative Erythrocytes
Plasmodium knowlesi can adapt to infect Duffy-negative Erythrocytes
PRJEB88498 | ENA
UnknownASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial.
Not available
S-EPMC9747535 | biostudies-literature
UnknownEffect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study.
Not available
S-EPMC11235734 | biostudies-literature
UnknownLong-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Not available
S-EPMC10842202 | biostudies-literature
Sort   by:  
 Page size